BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

569 related articles for article (PubMed ID: 19202204)

  • 1. Mutation analysis of the CFTR gene in Slovak cystic fibrosis patients by DHPLC and subsequent sequencing: identification of four novel mutations.
    Kolesár P; Minárik G; Baldovic M; Ficek A; Kovács L; Kádasi L
    Gen Physiol Biophys; 2008 Dec; 27(4):299-305. PubMed ID: 19202204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the CFTR gene in Iranian cystic fibrosis patients: identification of eight novel mutations.
    Alibakhshi R; Kianishirazi R; Cassiman JJ; Zamani M; Cuppens H
    J Cyst Fibros; 2008 Mar; 7(2):102-9. PubMed ID: 17662673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular analysis using DHPLC of cystic fibrosis: increase of the mutation detection rate among the affected population in Central Italy.
    D'Apice MR; Gambardella S; Bengala M; Russo S; Nardone AM; Lucidi V; Sangiuolo F; Novelli G
    BMC Med Genet; 2004 Apr; 5():8. PubMed ID: 15084222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved detection of CFTR mutations in Southern California Hispanic CF patients.
    Wong LJ; Wang J; Zhang YH; Hsu E; Heim RA; Bowman CM; Woo MS
    Hum Mutat; 2001 Oct; 18(4):296-307. PubMed ID: 11668613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Epidemiologic study of the cystic fibrosis gene in the Champagne-Ardenne region].
    Clavel C; Pennaforte F; Pigeon F; Mozelle M; Boutterin MC; Duval-Binninger I; F-erec C; Birembaut P
    Ann Biol Clin (Paris); 1996; 54(2):67-74. PubMed ID: 8763629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a novel mutation of CFTR gene in a Korean patient with cystic fibrosis.
    Ko JM; Kim GH; Kim KM; Hong SJ; Yoo HW
    J Korean Med Sci; 2008 Oct; 23(5):912-5. PubMed ID: 18955805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Relation between gene mutations and pancreatic exocrine function in patients with cystic fibrosis].
    Radivojević D; Guć-Sćekić M; Djurisić M; Lalić T; Minić P; Kanavakis E
    Srp Arh Celok Lek; 2001; 129 Suppl 1():6-9. PubMed ID: 15637983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Segregation analysis in cystic fibrosis at-risk family demonstrates that the M348K CFTR mutation is a rare innocuous polymorphism.
    D'Apice MR; Gambardella S; Russo S; Lucidi V; Nardone AM; Pietropolli A; Novelli G
    Prenat Diagn; 2004 Dec; 24(12):981-3. PubMed ID: 15614862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution of 9 common mutations in the CFTR gene in Slovak cystic fibrosis patients.
    Kádasi L; Poláková H; Zatková A; Kayserová H
    Gene Geogr; 1997 Apr; 11(1):51-6. PubMed ID: 9615214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cystic fibrosis transmembrane conductance regulator (CFTR) gene: mutations and clinical phenotypes].
    Schwartz M
    Ugeskr Laeger; 2003 Feb; 165(9):912-6. PubMed ID: 12661515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High incidence of the CFTR mutations 3272-26A-->G and L927P in Belgian cystic fibrosis patients, and identification of three new CFTR mutations (186-2A-->G, E588V, and 1671insTATCA).
    Storm K; Moens E; Vits L; De Vlieger H; Delaere G; D'Hollander M; Wuyts W; Biervliet M; Van Schil L; Desager K; Nöthen MM
    J Cyst Fibros; 2007 Nov; 6(6):371-5. PubMed ID: 17481968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutational spectrum of cystic fibrosis patients from Córdoba province and its zone of influence: implications of molecular diagnosis in Argentina.
    Ramírez AM; Ramos MD; Jiménez J; Ghio A; de Botelli MM; Rezzónico CA; Marqués I; Pereyro S; Casals T; de Kremer RD
    Mol Genet Metab; 2006 Apr; 87(4):370-5. PubMed ID: 16423550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Molecular basis of phenotype heterogeneity in cystic fibrosis].
    Bienvenu T
    Ann Biol Clin (Paris); 1997; 55(2):113-21. PubMed ID: 9180964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CFTR gene analysis in cystic fibrosis patients: detection of 91% of molecular defects and identification of the novel mutation D979V.
    Plouvier E; Cougoureux E; Sardet A; Tournier G; Aymard P; Feldmann D
    Ann Genet; 1997; 40(3):185-8. PubMed ID: 9401110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cystic fibrosis modifying genes].
    Knauer N; Ratjen F; Grasemann H
    Pneumologie; 2005 Jun; 59(6):395-404. PubMed ID: 15991075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterisation of mutations and genotype-phenotype correlation in cystic fibrosis: experience from India.
    Shastri SS; Kabra M; Kabra SK; Pandey RM; Menon PS
    J Cyst Fibros; 2008 Mar; 7(2):110-5. PubMed ID: 17716958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DHPLC screening of cystic fibrosis gene mutations.
    Ravnik-Glavac M; Atkinson A; Glavac D; Dean M
    Hum Mutat; 2002 Apr; 19(4):374-83. PubMed ID: 11933191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of CFTR mutations using temporal temperature gradient gel electrophoresis.
    Wong LJ; Alper OM
    Electrophoresis; 2004 Aug; 25(15):2593-601. PubMed ID: 15300780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cystic fibrosis: molecular update and clinical implications].
    Orozco L; Chávez M; Saldaña Y; Velázquez R; Carnevale A; González-del Angel A; Jiménez S
    Rev Invest Clin; 2006; 58(2):139-52. PubMed ID: 16827266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Identification of mutation in the gene cystic fibrosis transmembrane regulator (CFTR) in Chilean patients with cystic fibrosis].
    Repetto G; Poggi H; Harris P; Navarro H; Sánchez I; Guiraldes E; Pérez MA; Boza ML; Hunter B; Wevar ME; Mediavilla M; Foradori A
    Rev Med Chil; 2001 Aug; 129(8):841-7. PubMed ID: 11680956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.